No Reason to Get Excited about Athenahealth (ATHN), Thinks Oppenheimer
Tweet Send to a Friend
On Thursday Athenahealth (NASDAQ: ATHN) reported reported Q4 results, with EPS topping estimates by a penny on revenue of $116.3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
